OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$32.18
0.28 (0.88%)
▲
5d:
+12.24%
30d:
+52.22%
90d:
+174.34%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Distribution
None View Scanner →
Strength: 10.0/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called OSCR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OSCR trades at premium valuation expecting 17.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: OSCR trades at premium valuation expecting 17.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.74
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.06
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $32.18, which is considered extended relative to its 30-day fair value range of $23.42 to $30.16. From a valuation perspective, the stock is trading at a premium (Forward PE: 21.7) compared to its historical average (13.4). At these levels, the market is pricing in 17.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OSCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $22.60. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OSCR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $22.60. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.42 -
$30.16
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
OSCR is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+6.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 29.8% above Wall St target ($22.60)
- NEUTRAL: PE elevated vs history but 17.3% growth expectation is conservative given 126% recent growth
Trading Range Analysis
30-Day Trading Range
$23.42 -
$30.16
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$28.16
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.67
Wall Street Target
$22.60
(-29.8%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+17.3% premium
PE vs Historical
21.7 vs 13.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+17.3%
(market-implied from PE analysis)
1-Year Target
$37.75
(+17%)
2-Year Target
$44.28
(+38%)
3-Year Target
$51.94
(+61%)
3-Yr Target (if PE normalizes)
(PE: 22→13)
PE COMPRESSION
$32.11
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 40.3%)
$89.29
(+178%)
Base:
(SPY PE: 21.7, Growth: 40.3%)
$88.85
(+176%)
Bear:
(PE: 13.4, Growth: 40.3%)
$54.93
(+71%)
Share & Embed Analysis
Last updated: July 03, 2026 7:25 PM ET
Data refreshes hourly during market hours. Next update: 8:25 PM
Data refreshes hourly during market hours. Next update: 8:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Mario Schlosser
SELL
23038 shares
2026-01-08
Mario Schlosser
SELL
76962 shares
2026-01-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 62 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$411 | 59 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$419 | 63 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$304 | 61 BUY |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
